Wnt signaling plays a critical role in cancer development, with mutations in the Wnt pathway leading to the activation of β-catenin and subsequent gene expression changes that promote tumor growth. The Wnt pathway involves a complex network of proteins, including receptors, ligands, and signaling molecules such as GSK3β, dishevelled, and axin. Mutations in key components of this pathway, such as APC and β-catenin, are frequently observed in various cancers, including colorectal cancer, hepatocellular carcinoma, and desmoid tumors. These mutations often result in the stabilization of β-catenin, which then activates transcription factors like TCF/LEF, leading to the expression of genes involved in cell proliferation and survival. The Wnt signaling pathway is regulated by multiple mechanisms, including the phosphorylation and degradation of β-catenin by GSK3β. Disruptions in this regulation can lead to the accumulation of β-catenin, which promotes oncogenic transformation. Additionally, other proteins such as PP2A and the transcription factors TCF/LEF are involved in the regulation of Wnt signaling and can influence cancer progression. The interaction between Wnt signaling and other pathways, such as TGF-β and retinoic acid signaling, further complicates the role of Wnt in cancer. Mutations in the Wnt pathway are associated with various cancers, and understanding the molecular defects in this pathway is crucial for developing targeted therapies. The Wnt pathway's involvement in cancer is supported by extensive research, highlighting its importance in both the initiation and progression of tumors. Despite these findings, many aspects of Wnt signaling in cancer remain to be fully understood, and further research is needed to elucidate the complex interactions within this pathway.Wnt signaling plays a critical role in cancer development, with mutations in the Wnt pathway leading to the activation of β-catenin and subsequent gene expression changes that promote tumor growth. The Wnt pathway involves a complex network of proteins, including receptors, ligands, and signaling molecules such as GSK3β, dishevelled, and axin. Mutations in key components of this pathway, such as APC and β-catenin, are frequently observed in various cancers, including colorectal cancer, hepatocellular carcinoma, and desmoid tumors. These mutations often result in the stabilization of β-catenin, which then activates transcription factors like TCF/LEF, leading to the expression of genes involved in cell proliferation and survival. The Wnt signaling pathway is regulated by multiple mechanisms, including the phosphorylation and degradation of β-catenin by GSK3β. Disruptions in this regulation can lead to the accumulation of β-catenin, which promotes oncogenic transformation. Additionally, other proteins such as PP2A and the transcription factors TCF/LEF are involved in the regulation of Wnt signaling and can influence cancer progression. The interaction between Wnt signaling and other pathways, such as TGF-β and retinoic acid signaling, further complicates the role of Wnt in cancer. Mutations in the Wnt pathway are associated with various cancers, and understanding the molecular defects in this pathway is crucial for developing targeted therapies. The Wnt pathway's involvement in cancer is supported by extensive research, highlighting its importance in both the initiation and progression of tumors. Despite these findings, many aspects of Wnt signaling in cancer remain to be fully understood, and further research is needed to elucidate the complex interactions within this pathway.